Patents by Inventor Vanessa Smith

Vanessa Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for control of a virtual world
    Patent number: 11928275
    Abstract: Systems and methods for a controlling a shared virtual environment are provided. The systems and methods includes a public display connects to a reflector via a network. A shared virtual environment is replicated on the public display. A QR code is displayed on the public display for scanning by a mobile device. The QR code includes instructions to download a controller interface and location of the reflector. The mobile device provides inputs, via the reflector, to the shared virtual environment. This causes mirroring of computations on each of the plurality of objects across the shared virtual environment deterministically. Further, a new message from the reflector with an appended timestamp is transmitted to advance time within the public display. Inputs from the mobile device may include a touchscreen input corresponding to rendered joysticks and buttons, and/or an accelerometer input after position of the mobile device has been calibrated related to the public display.
    Type: Grant
    Filed: November 22, 2022
    Date of Patent: March 12, 2024
    Assignee: CEO Vision, Inc
    Inventors: Vanessa Ada Freudenberg, Aran Lunzer, Yoshiki Ohshima, David A. Smith, Brian Upton
  • Naphthylene derivatives as cytochrome P450 inhibitors
    Patent number: 7662844
    Abstract: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein n1, n2, n3, n4, G1, Q1, Z, R1, R2, R3, R4a, R4b, R5a, and R5b are defined herein, inhibit the cytochrome P450RAI enzyme and are useful for the treatment and/or prevention of various diseases and conditions which respond to treatment by retinoids and by naturally occurring retinoic acid.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: February 16, 2010
    Assignee: OSI Pharmaceuticals, Inc.
    Inventors: Vanessa Smith, Anthony Nigro, Mark Mulvihill, Cara Cesario, Patricia Anne Beck, Arlindo L. Castelhano
  • Naphthylene derivatives as cytochrome P450 inhibitors
    Publication number: 20060009645
    Abstract: Compounds of the formula and pharmaceutically acceptable salts thereof, wherein n1, n2, n3, n4, G1, Q1, Z, R1, R2, R3, R4a, R4b, R5a, and R5b are defined herein, inhibit the cytochrome P450RAI enzyme and are useful for the treatment and/or prevention of various diseases and conditions which respond to treatment by retinoids and by naturally occurring retinoic acid.
    Type: Application
    Filed: July 12, 2004
    Publication date: January 12, 2006
    Inventors: Vanessa Smith, Anthony Nigro, Mark Mulvihill, Cara Cesario, Patricia Beck, Arlindo Castelhano